|
1
|
Chow WH, Devesa SS, Warren JL and Fraumeni
JF Jr: Rising incidence of renal cell cancer in the United States.
JAMA. 281:1628–1631. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gupta K, Miller JD, Li JZ, Russell MW and
Charbonneau C: Epidemiologic and socioeconomic burden of metastatic
renal cell carcinoma (mRCC): A literature review. Cancer Treat Rev.
34:193–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hollingsworth JM, Miller DC, Daignault S
and Hollenbeck BK: Five-year survival after surgical treatment for
kidney cancer: A population-based competing risk analysis. Cancer.
109:1763–1768. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hunt JD, van der Hel OL, McMillan GP,
Boffetta P and Brennan P: Renal cell carcinoma in relation to
cigarette smoking: Meta-analysis of 24 studies. Int J Cancer.
114:101–108. 2005. View Article : Google Scholar
|
|
5
|
Yuan JM, Castelao JE, Gago-Dominguez M, Yu
MC and Ross RK: Tobacco use in relation to renal cell carcinoma.
Cancer Epidemiol Biomarkers Prev. 7:429–433. 1998.PubMed/NCBI
|
|
6
|
Bjørge Tand Tretli S and Engeland A:
Relation of height and body mass index to renal cell carcinoma in
two million Norwegian men and women. Am J Epidemiol. 160:1168–1176.
2004. View Article : Google Scholar
|
|
7
|
van Dijk BA, Schouten LJ, Kiemeney LA,
Goldbohm RA and van den Brandt PA: Relation of height, body mass,
energy intake and physical activity to risk of renal cell
carcinoma: Results from the Netherlands cohort study. Am J
Epidemiol. 160:1159–1167. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McLaughlin JK, Chow WH, Mandel JS,
Mellemgaard A, McCredie M, Lindblad P, Schlehofer B, Pommer W, Niwa
S and Adami HO: International renal-cell cancer study. VIII. Role
of diuretics, other anti-hypertensive medications and hypertension.
Int J Cancer. 63:216–221. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McCredie M, Pommer W, McLaughlin JK,
Stewart JH, Lindblad P, Mandel JS, Mellemgaard A, Schlehofer B and
Niwa S: International renal-cell cancer study. II. Analgesics. Int
J Cancer. 60:345–349. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
McDermott DF: Immunotherapy of metastatic
renal cell carcinoma. Cancer. 115(Suppl 10): 2298–2305. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Escudier B, Eisen T, Stadler WM, Szczylik
C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA,
et al: Sorafenib in advanced clear-cell renal-cell carcinoma. N
Engl J Med. 356:125–134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Motzer RJ, Hutson TE, Tomczak P,
Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik
C, Kim ST, et al: Sunitinib versus interferon alfa in metastatic
renal-cell carcinoma. N Engl J Med. 356:115–124. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang HT, Luo H, Wu J, Lan LB, Fan DH, Zhu
KD, Chen XY, Wen M and Liu HM: Galangin induces apoptosis of
hepatocellular carcinoma cells via the mitochondrial pathway. World
J Gastroenterol. 16:3377–3384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Capasso R and Mascolo N: Inhibitory effect
of the plant flavonoid galangin on rat vas deferens in vitro. Life
Sci. 72:2993–3001. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim DA, Jeon YK and Nam MJ: Galangin
induces apoptosis in gastric cancer cells via regulation of
ubiquitin carboxy-terminal hydrolase isozyme L1 and glutathione
S-transferase P. Food Chem Toxicol. 50:684–688. 2012. View Article : Google Scholar
|
|
16
|
Zhang W, Tang B, Huang Q and Hua Z:
Galangin inhibits tumor growth and metastasis of B16F10 melanoma. J
Cell Biochem. 114:152–161. 2013. View Article : Google Scholar
|
|
17
|
Heo MY, Sohn SJ and Au WW:
Anti-genotoxicity of galangin as a cancer chemopreventive agent
candidate. Mutat Res. 488:135–150. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi J, Wang DM, Wang CM, Hu Y, Liu AH,
Zhang YL, Sun B and Song JG: Insulin receptor substrate-1
suppresses transforming growth factor-beta1-mediated
epithelial-mesenchymal transition. Cancer Res. 69:7180–7187. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fan F, Samuel S, Evans KW, Lu J, Xia L,
Zhou Y, Sceusi E, Tozzi F, Ye XC, Mani SA and Ellis LM:
Overexpression of snail induces epithelial-mesenchymal transition
and a cancer stem cell-like phenotype in human colorectal cancer
cells. Cancer Med. 1:5–16. 2012. View
Article : Google Scholar
|
|
21
|
Saito RA, Watabe T, Horiguchi K, Kohyama
T, Saitoh M, Nagase T and Miyazono K: Thyroid transcription
factor-1 inhibits transforming growth factor-beta-mediated
epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
Cancer Res. 69:2783–2791. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
El-Najjar N, Chatila M, Moukadem H,
Vuorela H, Ocker M, Gandesiri M, Schneider-Stock R and
Gali-Muhtasib H: Reactive oxygen species mediate
thymoquinone-induced apoptosis and activate ERK and JNK signaling.
Apoptosis. 15:183–195. 2010. View Article : Google Scholar
|
|
25
|
Circu ML and Aw TY: Reactive oxygen
species, cellular redox systems and apoptosis. Free Radic Biol Med.
48:749–762. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gamaley IA and Klyubin IV: Roles of
reactive oxygen species: Signaling and regulation of cellular
functions. Int Rev Cytol. 188:203–255. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Parhiz H, Roohbakhsh A, Soltani F, Rezaee
R and Iranshahi M: Antioxidant and anti-inflammatory properties of
the citrus flavonoids hesperidin and hesperetin: an updated review
of their molecular mechanisms and experimental models. Phytother
Res. 29:323–31. 2015. View
Article : Google Scholar
|
|
28
|
Agati G, Azzarello E, Pollastri S and
Tattini M: Flavonoids as antioxidants in plants: location and
functional significance. Plant Sci. 2012 Nov;196:67–76. View Article : Google Scholar : PubMed/NCBI
|
